(Q56999671)

Soren Buus

6

0 references

Anne Searls De Groot

Anne S. De Groot

1

0 references

Kenneth Mayer

5

Kenneth H. Mayer

0 references

William D Martin

8

William D. Martin

0 references

Matthew T Ardito

3

Matthew T. Ardito

0 references

Gail Skowron

4

Gail Skowron

0 references

author name string

Christine M. Boyle

Human Vaccines & Immunotherapeutics

7

0 references

publication date

July 2012

0 references

published in

0 references

volume

8

0 references

issue

7

0 references

page(s)

987-1000

0 references

cites work

Clinical trials of HIV vaccines.

1 reference

Thirty years of HIV and AIDS: future challenges and opportunities

21 January 2018

1 reference

Adaptation of HIV-1 to human leukocyte antigen class I

21 January 2018

1 reference

HLA class I-driven evolution of human immunodeficiency virus type 1 subtype c proteome: immune escape and viral load

21 January 2018

1 reference

Lessons drawn from recent HIV vaccine efficacy trials

21 January 2018

1 reference

Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand

21 January 2018

1 reference

Immune-correlates analysis of an HIV-1 vaccine efficacy trial

21 January 2018

1 reference

Key issues for a potential human immunodeficiency virus vaccine

21 January 2018

1 reference

Requirement for CD4 T Cell Help in Generating Functional CD8 T Cell Memory

21 January 2018

1 reference

Requirement of diverse T-helper responses elicited by HIV vaccines: induction of highly targeted humoral and CTL responses

21 January 2018

1 reference

A DNA vaccine encoding multiple HIV CD4 epitopes elicits vigorous polyfunctional, long-lived CD4+ and CD8+ T cell responses

21 January 2018

1 reference

Cytotoxic-T-cell responses, viral load, and disease progression in early human immunodeficiency virus type 1 infection

21 January 2018

1 reference

Relationship between functional profile of HIV-1 specific CD8 T cells and epitope variability with the selection of escape mutants in acute HIV-1 infection

21 January 2018

1 reference

Variable fitness impact of HIV-1 escape mutations to cytotoxic T lymphocyte (CTL) response

21 January 2018

1 reference

Human immunodeficiency virus type 1-specific CD8+ T-cell responses during primary infection are major determinants of the viral set point and loss of CD4+ T cells

21 January 2018

1 reference

HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins

21 January 2018

1 reference

Nef-specific CD45RA+ CD8+ T cells secreting MIP-1beta but not IFN-gamma are associated with nonprogressive HIV-1 infection.

21 January 2018

1 reference

In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells

21 January 2018

1 reference

Selective escape from CD8+ T-cell responses represents a major driving force of human immunodeficiency virus type 1 (HIV-1) sequence diversity and reveals constraints on HIV-1 evolution

21 January 2018

1 reference

Identification of immunogenic HLA-B7 "Achilles' heel" epitopes within highly conserved regions of HIV

21 January 2018

1 reference

HLA footprints on human immunodeficiency virus type 1 are associated with interclade polymorphisms and intraclade phylogenetic clustering

21 January 2018

1 reference

Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope

21 January 2018

1 reference

Consistent cytotoxic-T-lymphocyte targeting of immunodominant regions in human immunodeficiency virus across multiple ethnicities

21 January 2018

1 reference

Protective HLA class I alleles that restrict acute-phase CD8+ T-cell responses are associated with viral escape mutations located in highly conserved regions of human immunodeficiency virus type 1.

21 January 2018

1 reference

Increasing CTL targeting of conserved sequences during early HIV-1 infection is correlated to decreasing viremia

21 January 2018

1 reference

Enhanced anti-HIV functional activity associated with Gag-specific CD8 T-cell responses

21 January 2018

1 reference

HLA-associated clinical progression correlates with epitope reversion rates in early human immunodeficiency virus infection

21 January 2018

1 reference

Lessons learned from natural infection: focusing on the design of protective T cell vaccines for HIV/AIDS.

21 January 2018

1 reference

The organization of human leucocyte antigen class I epitopes in HIV genome products: implications for HIV evolution and vaccine design

21 January 2018

1 reference

HLA class I supertypes: a revised and updated classification

21 January 2018

1 reference

Confirmation of immunogenic consensus sequence HIV-1 T-cell epitopes in Bamako, Mali and Providence, Rhode Island

21 January 2018

1 reference

Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations

21 January 2018

1 reference

Immunoinformatic comparison of T-cell epitopes contained in novel swine-origin influenza A (H1N1) virus with epitopes in 2008-2009 conventional influenza vaccine

21 January 2018

1 reference

Inter-clade cross-reactivity of HIV-1-specific T cell responses in human immunodeficiency virus type 1 infection in China

21 January 2018

1 reference

Ex vivo expansion of HIV type 1-specific cytolytic T cells from HIV type 1-seropositive subjects

21 January 2018

1 reference

An HLA-directed molecular and bioinformatics approach identifies new HLA-A11 HIV-1 subtype E cytotoxic T lymphocyte epitopes in HIV-1-infected Thais.

21 January 2018

1 reference

Screening for CD8 cytotoxic T lymphocytes specific for Gag of human immunodeficiency virus type 1 subtype B' Henan isolate from China and identification of novel epitopes restricted by the HLA-A2 and HLA-A11 alleles

21 January 2018

1 reference

Skewed association of polyfunctional antigen-specific CD8 T cell populations with HLA-B genotype

21 January 2018

1 reference

Extensive HLA class I allele promiscuity among viral CTL epitopes

21 January 2018

1 reference

Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design

21 January 2018

1 reference

Recombinant modified vaccinia virus Ankara efficiently restimulates human cytotoxic T lymphocytes in vitro

21 January 2018

1 reference

Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation.

21 January 2018

1 reference

HIV-1-specific cytotoxic T lymphocyte (CTL) responses against immunodominant optimal epitopes slow the progression of AIDS in China

21 January 2018

1 reference

Peptide selection for human immunodeficiency virus type 1 CTL-based vaccine evaluation

21 January 2018

1 reference

Transition from long-term nonprogression to HIV-1 disease associated with escape from cellular immune control.

21 January 2018

1 reference

Spreading of HIV-specific CD8+ T-cell repertoire in long-term nonprogressors and its role in the control of viral load and disease activity

21 January 2018

1 reference

Broadly immunogenic HLA class I supertype-restricted elite CTL epitopes recognized in a diverse population infected with different HIV-1 subtypes.

21 January 2018

1 reference

CD8+ T-cell responses to different HIV proteins have discordant associations with viral load

21 January 2018

1 reference

Identification and characterization of HLA-A*0301 epitopes in HIV-1 gag proteins using a novel approach

21 January 2018

1 reference

Design and pre-clinical evaluation of a universal HIV-1 vaccine

21 January 2018

1 reference

Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants.

21 January 2018

1 reference

Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys

21 January 2018

1 reference

T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces

21 January 2018

1 reference

HIV-1 group M conserved elements vaccine

21 January 2018

1 reference

Coping with viral diversity in HIV vaccine design: a response to Nickle et al.

21 January 2018

1 reference

Comparison of immunogen designs that optimize peptide coverage: reply to Fischer et al.

21 January 2018

1 reference

From genome to vaccine: in silico predictions, ex vivo verification.

21 January 2018

1 reference

An interactive Web site providing major histocompatibility ligand predictions: application to HIV research

21 January 2018

1 reference

Establishment of a quantitative ELISA capable of determining peptide - MHC class I interaction

21 January 2018

1 reference

Moving to human immunodeficiency virus type 1 vaccine efficacy trials: defining T cell responses as potential correlates of immunity

21 January 2018

1 reference

Immune responses driven by protective human leukocyte antigen alleles from long-term nonprogressors are associated with low HIV reservoir in central memory CD4 T cells.

21 January 2018

1 reference